Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Facility Certification and Inspection (MQSA)

Facility Certification and Inspection (MQSA)

                        Mammography Safety Notifications
          Inspection News
          Digital Accreditation
          Facilities - Mammography Quality Standards Act Requirements
          Facility Certification and Inspection Mammography Quality Standards Act (MQSA): Inspection Fees
          MQSA:  Accreditation Bodies
          Residency Letter for Residency Graduates of 2014 or Later
          Facility Certification and Inspection: CMS Reimbursement Issues
          Inspection Procedures
          Preparing for an Inspection
          Revised MQSA Policy on Follow Up for Inspection Violations Home
          Radiation-Emitting Products
          Mammography Quality Standards Act and Program
          Facility Certification and Inspection (MQSA)
          Digital AccreditationFacility Certification and Inspection (MQSA) Digital Accreditation
  
  	
    Share
    Post
    Linkedin

    Email
    Print*Note to MAMMOGRAPHY FACILITY STAFF: If you have questions about the MQSA Program, please call the MQSA Facility Hotline at 1-800-838-7715 or email your questions to MQSAhotline@versatechinc.com*
Effective April 9, 2018, all FDA MQSA accreditation bodies (AB) are approved to accredit DBT mammography systems. After April 6, 2018, the FDA's certificate extension program will no longer be accepting applications to approve the use of DBT based on a facility's existing FFDM accreditation. That means all facilities must now have their existing and future DBT units accredited by their AB. All MQSA certificate extensions for the use of DBT units that have been granted to date will remain in effect until the AB and the facility complete the transition of those DBT units to their AB's accreditation program. Contact information for the each AB can be found on our Accreditation Bodies page. Any applications received by the FDA after April 6, 2018, will be returned to the facility.
Please contact your AB for information on the types of images it accepts for accreditation as well as on how to submit images.
For answers to commonly asked questions regarding new modality training for personnel prior to using DBT systems, please see our page Frequently Asked  Questions about DBT and MQSA.
The primary purpose of the FDA's certificate extension program has always been to provide a temporary way for new technology to be available to benefit patients when ABs did not have standards developed, or the processes in place, to accredit a new mammography technology. This is the pathway that was taken when FFDM first entered the market, and more recently, when DBT first entered the market. Once an AB is ready to accredit the new mammography technology, applies to FDA for approval to accredit, and is approved to do so, the transition from the certificate extension program to the AB occurs, as accreditation is mandated by the MQSA. FDA works closely with the ABs to assist facilities with this transition; however, individual ABs can establish their own accreditation procedures within the confines of the MQSA requirements for accreditation.
DBT Systems
Below is a list of DBT units approved by FDA for marketing, with their respective dates of market approval:
GE Senographe Pristina with Digital Breast Tomosynthesis (DBT) Option - 03/3/2017
    Fujifilm ASPIRE Cristalle with Digital Breast Tomosynthesis (DBT) Option - 01/10/2017
    Siemens MAMMOMAT Inspiration with Digital Breast Tomosynthesis (DBT) Option - 04/21/2015
    GE SenoClaire Digital Breast Tomosynthesis (DBT) System - 08/26/2014
    Hologic Selenia Dimensions Digital Breast Tomosynthesis (DBT) System - 02/11/2011

                                                                                  Content current as of:
      05/16/2018Facility Certification and Inspection (MQSA)

          
                        Mammography Safety Notifications
          Inspection News
          Digital Accreditation
          Facilities - Mammography Quality Standards Act Requirements
          Facility Certification and Inspection Mammography Quality Standards Act (MQSA): Inspection Fees
          MQSA:  Accreditation Bodies
          Residency Letter for Residency Graduates of 2014 or Later
          Facility Certification and Inspection: CMS Reimbursement Issues
          Inspection Procedures
          Preparing for an Inspection
          Revised MQSA Policy on Follow Up for Inspection Violations
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop